Literature DB >> 21670304

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.

Tiziana Schioppa1, Robert Moore, Richard G Thompson, Elizabeth C Rosser, Hagen Kulbe, Sergei Nedospasov, Claudia Mauri, Lisa M Coussens, Frances R Balkwill.   

Abstract

The inflammatory cytokine TNF-α has been recognized as a critical tumor promoter, but the effector cells that mediate its action have not been fully characterized. Because B cells regulate squamous and prostate carcinogenesis, and Tnf(-/-) mice harbor B-cell defects, we investigated the hypothesis that B cells are important effector cells for TNF-α-mediated promotion of cancer development. Using an adoptive transfer strategy and the 7,12-dimethylbenz[α]anthracene/terephthalic acid (DMBA/TPA) two-stage model of skin carcinogenesis, we found that both B cells and TNF-α are critical for the development of DMBA/TPA-induced papilloma. Transfer of B cells from DMBA/TPA-treated wild-type mice to Tnf(-/-) mice rescued papilloma development to a wild-type level, a result not observed when B cells from Tnf(-/-) mice were transferred to Rag2(-/-) mice or when TNF-α was eliminated selectively in B cells. Resistance to papilloma development in Tnf(-/-) mice was associated with increased IFN-γ and CD8(+) T cells in skin and a significant reduction in IL-10-producing B regulatory cells alongside an increase in IFN-γ-producing CD8(+) T cells in the spleen. These data indicate that during DMBA/TPA-induced squamous carcinogenesis TNF-α mediates tumor-promoting activity via regulatory B cells that repress antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670304      PMCID: PMC3127875          DOI: 10.1073/pnas.1100994108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Novel tumor necrosis factor-knockout mice that lack Peyer's patches.

Authors:  Dmitry V Kuprash; Alexei V Tumanov; Dmitry J Liepinsh; Ekaterina P Koroleva; Marina S Drutskaya; Andrei A Kruglov; Alexander N Shakhov; Eileen Southon; William J Murphy; Lino Tessarollo; Sergei I Grivennikov; Sergei A Nedospasov
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

2.  B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.

Authors:  Massimo Ammirante; Jun-Li Luo; Sergei Grivennikov; Sergei Nedospasov; Michael Karin
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

3.  De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

Authors:  Karin E de Visser; Lidiya V Korets; Lisa M Coussens
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

4.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

5.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 6.  Signaling in transitional type 2 B cells is critical for peripheral B-cell development.

Authors:  Thomas T Su; Beichu Guo; Bo Wei; Jonathan Braun; David J Rawlings
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

7.  The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

Authors:  Kellie A Charles; Hagen Kulbe; Robin Soper; Monica Escorcio-Correia; Toby Lawrence; Anne Schultheis; Probir Chakravarty; Richard G Thompson; George Kollias; John F Smyth; Frances R Balkwill; Thorsten Hagemann
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

Review 8.  Regulatory B cells as inhibitors of immune responses and inflammation.

Authors:  Jean-David Bouaziz; Koichi Yanaba; Thomas F Tedder
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

9.  The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.

Authors:  Hagen Kulbe; Richard Thompson; Julia L Wilson; Stephen Robinson; Thorsten Hagemann; Rewas Fatah; David Gould; Ayse Ayhan; Frances Balkwill
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

10.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  130 in total

1.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

Authors:  Andrew J Gunderson; Megan M Kaneda; Takahiro Tsujikawa; Abraham V Nguyen; Nesrine I Affara; Brian Ruffell; Sara Gorjestani; Shannon M Liudahl; Morgan Truitt; Peter Olson; Grace Kim; Douglas Hanahan; Margaret A Tempero; Brett Sheppard; Bryan Irving; Betty Y Chang; Judith A Varner; Lisa M Coussens
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

Review 4.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

Review 5.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

Review 6.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

7.  Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

Authors:  Andrew H Ko; Alexander C Jordan; Evan Tooker; Simon F Lacey; Renee B Chang; Yan Li; Alan P Venook; Margaret Tempero; Lloyd Damon; Lawrence Fong; Mark H O'Hara; Bruce L Levine; J Joseph Melenhorst; Gabriela Plesa; Carl H June; Gregory L Beatty
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 8.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

9.  Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.

Authors:  K Hayashi; Y Momoi; N Tanuma; A Kishimoto; H Ogoh; H Kato; M Suzuki; Y Sakamoto; Y Inoue; M Nomura; H Kiyonari; M Sakayori; K Fukamachi; Y Kakugawa; Y Yamashita; S Ito; I Sato; A Suzuki; M Nishio; M Suganuma; T Watanabe; H Shima
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

Review 10.  B cells and their mediators as targets for therapy in solid tumors.

Authors:  Andrew J Gunderson; Lisa M Coussens
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.